Evolution and emergence of novel human infections.
Some zoonotic pathogens cause sporadic infection in humans but rarely propagate further, while others have succeeded in overcoming the species barrier and becoming established in the human population. Adaptation, driven by selection pressure in human hosts, can play a significant role in allowing pathogens to cross this species barrier. Here we use a simple mathematical model to study potential epidemiological markers of adaptation. We ask: under what circumstances could ongoing adaptation be signalled by large clusters of human infection? If a pathogen has caused hundreds of cases but with little transmission, does this indicate that the species barrier cannot be crossed? Finally, how can case reports be monitored to detect an imminent emergence event? We distinguish evolutionary scenarios under which adaptation is likely to be signalled by large clusters of infection and under which emergence is likely to occur without any prior warning. Moreover, we show that a lack of transmission never rules out adaptability, regardless of how many zoonoses have occurred. Indeed, after the first 100 zoonotic cases, continuing sporadic zoonotic infections without onward, human-to-human transmission offer little extra information on pathogen adaptability. Finally, we present a simple method for monitoring outbreaks for signs of emergence and discuss public health implications.
Arinaminpathy
N
N
Department of Zoology, Institute for Emerging Infections, James Martin 21st Century School, University of Oxford, Oxford OX1 3PS, UK. nim.pathy@zoo.ox.ac.uk
McLean
A R
AR
D005075:Biological Evolution; D021821:Communicable Diseases, Emerging / Q000453:epidemiology* / Q000635:transmission; D004196:Disease Outbreaks; D006801:Humans; D053124:Influenza A Virus, H5N1 Subtype; D007251:Influenza, Human / Q000453:epidemiology* / Q000635:transmission*; D008954:Models, Biological
Nature. 2009 Jun 25;459(7250):1122-5
19516283
Nature. 2008 Feb 21;451(7181):990-3
18288193
Science. 2003 Oct 10;302(5643):276-8
12958366
PLoS Pathog. 2009 May;5(5):e1000455
19478873
Nature. 2005 Nov 17;438(7066):355-9
16292310
Nature. 2003 Dec 11;426(6967):658-61
14668863
N Engl J Med. 2005 Sep 29;353(13):1374-85
16192482
Nature. 2007 May 17;447(7142):279-83
17507975
Proc Biol Sci. 2006 Dec 22;273(1605):3075-83
17015347
Nature. 2004 Jul 8;430(6996):242-9
15241422
Science. 2006 Jul 28;313(5786):523-6
16728595
Trends Ecol Evol. 2005 May;20(5):238-44
16701375
Philos Trans R Soc Lond B Biol Sci. 2001 Jun 29;356(1410):901-10
11405937
Proc Biol Sci. 2005 Sep 22;272(1575):1949-56
16191602
Nat Rev Genet. 2004 Jan;5(1):52-61
14708016
Science. 2005 Oct 28;310(5748):676-9
16195424